Our results indicate that use of blood-based diagnostics may be inaccurate at this acute stage of disease and possibly accounts for the reduced sensitivity for active TB disease with the current IFN-γ release assays (IGRAs) [17]. The gene discussed is IFNG; the disease is tuberculosis.